Business
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026
GARDEN CITY, N.Y., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors and subsidiary of Beyond Air, Inc. (NASDAQ: XAIR), today announced being selected to present an abstract featuring data from the Phase 1 trial of intratumoral UNO in solid tumor metastases at the American Association for Cancer Research (AACR) Annual Meeting 2026, which is scheduled to be h
About this update from Beyond Air, Inc.
[{"type":"image","alt":"Beyond Air™","displaySize":"","headline":null,"caption":"Beyond Air™","className":"","disableSlideshowImg":false,"size":{"original":{"width":264,"height":50,"url":"https://media.zenfs.com/en/globenewswire.com/283e6374c7eeb2f53ca652917eb5334d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cVMIN3hdiWRLf4negBQkjw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTgwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/283e6374c7eeb2f53ca652917eb5334d","width":264,"height":50}},"lazy":false},{"type":"text","content":"GARDEN CITY, N.Y., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors and subsidiary of Beyond Air, Inc. (NASDAQ: XAIR), today announced being selected to present an abstract featuring data from the Phase 1 trial of intratumoral UNO in solid tumor metastases at the American Association for Cancer Research (AACR) Annual Meeting 2026, which is scheduled to be held from Friday, April 17th, through Wednesday, April 22nd, at the San Diego Convention Center in San Diego, California. The original submitted abstract titles and text are scheduled to be published in an Online Itinerary Planner on March 17, 2026 at 4:30 PM ET / 1:30 PM PT.","length":775,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"3","val":[{"type":"text","content":"AACR Annual Meeting 2026 Abstract Details:","length":42,"tagName":"p"}]}]},{"val":[{"style":"max-width:30%;width:30%;min-width:30%;","val":[{"type":"text","content":"Presenter:","length":10,"tagName":"p","attribs":{}}]},{"style":"max-width:1%;width:1%;min-width:1%;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"max-width:69%;width:69%;min-width:69%;","val":[{"type":"text","content":"Amichay Meirovitz, MD, Soroka University Medical Center, Beersheba, Israel","length":74,"tagName":"p","attribs":{}}]}]},{"val":[{"val":[{"type":"text","content":"Session Category: ","length":18,"tagName":"p"}]},{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]},{"val":[{"type":"text","content":"Experimental and Molecular Therapeutics","length":39,"tagName":"p"}]}]},{"val":[{"val":[{"type":"text","content":"Session Title:","length":14,"tagName":"p"}]},{"val":[{"type":"text","content":" ...